Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin Treatment of Alcohol Dependence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women over age 18 with alcohol dependence~Exclusion Criteria:~* Currently meets Diagnostic and Statistical Manual 4 Text Revision (DSM-IV-TR) criteria for dependence on illicit substances~* Significant medical disorders that will increase potential risk or interfere with study participation~* Women with childbearing potential who are pregnant, nursing, or refuse to use a reliable method of birth control~* Treatment with an investigational drug in the last month.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- gabapentin 900mg daily (Type: EXPERIMENTAL): 900mg gabapentin daily for 12 weeks and weekly concomitant manualized behavioral counseling for 12 weeks.
- gabapentin 1800mg daily (Type: EXPERIMENTAL): 1800 mg gabapentin daily for 12 weeks and weekly concomitant manualized behavioral counseling for 12 weeks
- placebo daily (Type: PLACEBO_COMPARATOR): placebo capsules daily for 12 weeks and weekly concomitant manualized behavioral counseling for 12 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).